No Data
C-MER MEDICAL (03309.HK) purchased 336,000 shares for 0.521 million Hong Kong dollars on March 25.
Gelonghui reported on March 25 that C-MER MEDICAL (03309.HK) announced that on March 25, 2025, it spent 0.521 million HKD to repurchase 0.336 million shares, with a repurchase price of 1.54-1.57 HKD per share.
C-MER MEDICAL (03309.HK) spent 1.367 million Hong Kong dollars to buy back 0.88 million shares on March 24.
On March 24, Gelonghui reported that C-MER MEDICAL (03309.HK) announced the repurchase of 0.88 million shares for a total cost of 1.367 million Hong Kong dollars on March 24, 2025, with a repurchase price of 1.54-1.57 Hong Kong dollars per share.
Hong Kong Stock Morning Report｜Our country will implement comprehensive measures to expand consumption. Most China Concept Stocks are down.
1. The country will implement comprehensive measures to expand consumption; the new policy on consumer loans allows for the personal consumption loan self-payment cap to be increased from 0.3 million yuan to 0.5 million yuan in stages. 2. Trump and the U.S. Secretary of Defense made speeches stating that Russia and Ukraine will soon achieve a complete ceasefire. 3. The three major U.S. stock indices rose last Friday, while most China Concept Stocks declined. 4. Speculative traders have shifted to Put the dollar for the first time since Trump's victory.
C-MER Medical Holdings Declares Final Dividend for 2024
C-MER MEDICAL (03309) will distribute a final dividend of HKD 0.02 per share on July 15.
C-MER MEDICAL (03309) announced that it will distribute dividends on July 15, 2025, up to December 3, 2024...
C-MER Medical Holdings Reports 2024 Annual Results With Revenue Decline
C-MER Eye Care Holdings (HKG:3309 Investor Three-year Losses Grow to 49% as the Stock Sheds HK$449m This Past Week
